Terms: = Liver cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK
2231 results:
1. Activation of the MEK/erk Pathway Mediates the Inhibitory Effects of Silvestrol on Nasopharyngeal Carcinoma Cells via RAP1A, HK2, and GADD45A.
Yu LR; Han XZ; Tang YZ; Liu D; Luo XQ; Qiu XW; Feng J; Yuan WX; Ding JY
Front Biosci (Landmark Ed); 2024 Apr; 29(4):160. PubMed ID: 38682208
[TBL] [Abstract] [Full Text] [Related]
2. CDK4/6 inhibition sensitizes MEK inhibition by inhibiting cell cycle and proliferation in pancreatic ductal adenocarcinoma.
Cheng K; Zhou Z; Chen Q; Chen Z; Cai Y; Cai H; Wu S; Gao P; Cai Y; Zhou J; Wang X; Wu Z; Peng B
Sci Rep; 2024 Apr; 14(1):8389. PubMed ID: 38600093
[TBL] [Abstract] [Full Text] [Related]
3. [Single extract of Forsythia Suspense versus the prepared drug in pieces: comparison of their anti-inflammatory, antitumor and antibacterial effects in zebrafish].
Guo X; Guo Z; Sun D; Zou L; Ou J; Yu L; Lu Z; Cao H; Liu J
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Mar; 44(3):594-604. PubMed ID: 38597452
[TBL] [Abstract] [Full Text] [Related]
4. Integrated network toxicology, molecular docking, and in vivo experiments to elucidate molecular mechanism of aflatoxin B1 hepatotoxicity.
Ge B; Yan K; Sang R; Wang W; Liu X; Yu M; Liu X; Qiu Q; Zhang X
Ecotoxicol Environ Saf; 2024 Apr; 275():116278. PubMed ID: 38564860
[TBL] [Abstract] [Full Text] [Related]
5. Investigation of prunetrin induced G2/M cell cycle arrest and apoptosis via Akt/mTOR/MAPK pathways in hepatocellular carcinoma cells.
Abusaliya A; Bhosale PB; Kim HH; Park MY; Jeong SH; Lee S; Kim GS
Biomed Pharmacother; 2024 May; 174():116483. PubMed ID: 38552440
[TBL] [Abstract] [Full Text] [Related]
6. Tyrosine phosphatase
Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
[TBL] [Abstract] [Full Text] [Related]
7. Exosomal IGFBP2 derived from highly metastatic promotes hepatocellular carcinoma metastasis by inducing epithelial mesenchymal transition.
Zheng Y; Li W; Huang Y; Cheng H
Gene; 2024 Jun; 913():148374. PubMed ID: 38490505
[TBL] [Abstract] [Full Text] [Related]
8. liver-derived plasminogen mediates muscle stem cell expansion during caloric restriction through the plasminogen receptor Plg-R
Bareja A; Lee DE; Ho T; Waitt G; McKay LH; Hannou SA; Orenduff MC; McGreevy KM; Binder A; Ryan CP; Soderblom EJ; Belsky DW; Ferrucci L; Das JK; Banskota N; Kraus VB; Huebner JL; Kraus WE; Huffman KM; Baht GS; Horvath S; Parmer RJ; Miles LA; White JP
Cell Rep; 2024 Mar; 43(3):113881. PubMed ID: 38442019
[TBL] [Abstract] [Full Text] [Related]
9. Icaritin activates p53 and inhibits aerobic glycolysis in liver cancer cells.
Zhou X; Wu D; Mi T; Li R; Guo T; Li W
Chem Biol Interact; 2024 Apr; 392():110926. PubMed ID: 38431053
[TBL] [Abstract] [Full Text] [Related]
10. Role of Macrophages in liver Fibrosis.
Sun C; Matsukawa A
Acta Med Okayama; 2024 Feb; 78(1):1-8. PubMed ID: 38419308
[TBL] [Abstract] [Full Text] [Related]
11. Integrative single-cell transcriptomic analyses reveal the cellular ontological and functional heterogeneities of primary and metastatic liver tumors.
Gui M; Huang S; Li S; Chen Y; Cheng F; Liu Y; Wang JA; Wang Y; Guo R; Lu Y; Cao P; Zhou G
J Transl Med; 2024 Feb; 22(1):206. PubMed ID: 38414027
[TBL] [Abstract] [Full Text] [Related]
12. Network pharmacology analysis and experimental verification of the antitumor effect and molecular mechanism of isocryptomerin on HepG2 cells.
Cao JL; Li SM; Tang YJ; Hou WS; Wang AQ; Li TZ; Jin CH
Drug Dev Res; 2024 Apr; 85(2):e22165. PubMed ID: 38400652
[TBL] [Abstract] [Full Text] [Related]
13. Role of Wisteria floribunda agglutinin binding glycans in carcinogenesis and metastasis of cholangiocarcinoma.
Phuyathip W; Putthisen S; Panawan O; Ma-In P; Teeravirote K; Sintusen P; Udomkitkosol S; Detarya M; Luang S; Mahalapbutr P; Sato T; Kuno A; Chuangchaiya S; Silsirivanit A
Histochem Cell Biol; 2024 May; 161(5):423-434. PubMed ID: 38393396
[TBL] [Abstract] [Full Text] [Related]
14. Disruption of MerTK increases the efficacy of checkpoint inhibitor by enhancing ferroptosis and immune response in hepatocellular carcinoma.
Wang S; Zhu L; Li T; Lin X; Zheng Y; Xu D; Guo Y; Zhang Z; Fu Y; Wang H; Wang X; Zou T; Shen X; Zhang L; Lai N; Lu L; Qin L; Dong Q
Cell Rep Med; 2024 Feb; 5(2):101415. PubMed ID: 38382467
[TBL] [Abstract] [Full Text] [Related]
15. The Herbal Combination Shu Gan Jie Yu Regulates the SNCG/ER-a/AKT-erk Pathway in DMBA-Induced Breast cancer and Breast cancer Cell Lines Based on RNA-Seq and IPA Analysis.
Zhao Y; Zhao L; Wang T; Liu Z; Tang S; Huang H; Wu L; Sun Y
Integr Cancer Ther; 2024; 23():15347354241233258. PubMed ID: 38369762
[TBL] [Abstract] [Full Text] [Related]
16. l-Methionine potentiates anticancer activity of Sorafenib by epigenetically altering DUSP3/erk pathway in hepatocellular carcinoma.
Pal S; Kabeer SW; Sharma S; Tikoo K
J Biochem Mol Toxicol; 2024 Mar; 38(3):e23663. PubMed ID: 38367245
[TBL] [Abstract] [Full Text] [Related]
17. CircPCNXL2 promotes tumor growth and metastasis by interacting with STRAP to regulate erk signaling in intrahepatic cholangiocarcinoma.
Liu S; Wang Y; Wang T; Shi K; Fan S; Li C; Chen R; Wang J; Jiang W; Zhang Y; Chen Y; Xu X; Yu Y; Li C; Li X
Mol Cancer; 2024 Feb; 23(1):35. PubMed ID: 38365721
[TBL] [Abstract] [Full Text] [Related]
18. Homeobox Protein BarH-like 1 Promotes Gastric cancer Progression by Activating Coiled-Coil Domain-Containing Protein 178.
Gu Y; Chen G; Ning X
Dig Dis Sci; 2024 Apr; 69(4):1182-1199. PubMed ID: 38358459
[TBL] [Abstract] [Full Text] [Related]
19. Dipsacus Asperoides-Derived Exosomes-Like Nanoparticles Inhibit the Progression of Osteosarcoma via Activating p38/JNK Signaling Pathway.
Lu J; Chen J; Ye J; Shi Z; Gao X; Chen P; Chang Y; Lin H; Li P
Int J Nanomedicine; 2024; 19():1097-1108. PubMed ID: 38327597
[TBL] [Abstract] [Full Text] [Related]
20. PP4R1 promotes glycolysis and gallbladder cancer progression through facilitating erk1/2 mediated PKM2 nuclear translocation.
He Z; Zhong Y; Lv T; Wang J; Jin Y; Li F; Hu H
Cancer Lett; 2024 Apr; 586():216677. PubMed ID: 38301910
[TBL] [Abstract] [Full Text] [Related]
[Next]
